Retraction: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization (Proc. Natl. Acad. Sci. U.S.A. (2009) 106 (17910–17915) DOI: 10.1073/pnas.0909353106)

David Z. Qian, Sergio Rey, Jun O. Liu, Gregg L. Semenza

Research output: Contribution to journalComment/debatepeer-review

Abstract

The undersigned authors note, “We are retracting this article due to issues regarding the bottom panel of Figure 2D. Visible in this blot are the GST-HIF-1β band of interest at the top, a faint doublet in the middle, and a strong band migrating just above GST at the bottom, which is likely a degradation product of GST-HIF-1β. It appears that in the middle doublet, lanes 2, 5, and 8 are duplicate images; lanes 3, 6, and 9 are duplicate images; and lanes 4 and 7 are duplicate images. There is also concern of possible manipulation of the data shown across the bottom band. We believe that the overall conclusions of the paper remain valid, but we are retracting the work due to these underlying concerns about the figure. We apologize for the inconvenience.”

Original languageEnglish (US)
Article numbere2305537120
JournalProceedings of the National Academy of Sciences of the United States of America
Volume120
Issue number118
DOIs
StatePublished - May 2 2023

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Retraction: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization (Proc. Natl. Acad. Sci. U.S.A. (2009) 106 (17910–17915) DOI: 10.1073/pnas.0909353106)'. Together they form a unique fingerprint.

Cite this